The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastatic melanoma, glioblastoma and high-grade extrapulmonary neuroendocrine carcinomas (NECs) as novel indications for rovalpituzumab tesirine: A delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC).
 
Stanford L. Peng
Employment - Seagen; Stem CentRx
 
Laura Saunders
Employment - Stem CentRx
Stock and Other Ownership Interests - Stem CentRx
Research Funding - Stem CentRx
Patents, Royalties, Other Intellectual Property - Stem CentRx
Travel, Accommodations, Expenses - Stem CentRx
Other Relationship - Stem CentRx
 
Sheila Bheddah
Employment - Stem CentRx
Stock and Other Ownership Interests - Stem CentRx
Research Funding - Stem CentRx
Travel, Accommodations, Expenses - Stem CentRx
Other Relationship - Stem CentRx
 
Sam Williams
Employment - Stem CentRx
Stock and Other Ownership Interests - Stem CentRx
Research Funding - Stem CentRx
Travel, Accommodations, Expenses - Stem CentRx
Other Relationship - Saladax Biomedical
 
Rahul Raj Aggarwal
Research Funding - Janssen; Novartis; Sanofi
 
Jill E. Shea
No Relationships to Disclose
 
Eun Y Lee
No Relationships to Disclose
 
Jiaoti Huang
No Relationships to Disclose
 
Allison J Zemek
No Relationships to Disclose
 
Teri A. Longacre
No Relationships to Disclose
 
Douglas Wilmot Ball
No Relationships to Disclose
 
Courtney L. Scaife
No Relationships to Disclose
 
Barry Nelkin
No Relationships to Disclose
 
Lowell Brian Anthony
No Relationships to Disclose
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Advanced Accelerator Applications; Esanex; Genentech/Roche; Lexicon; Merck; Novartis; Oxigene
 
Eric Jay Small
No Relationships to Disclose
 
Scott Dylla
Employment - Stem CentRx
Leadership - Stem CentRx
Stock and Other Ownership Interests - Stem CentRx
Research Funding - Stem CentRx
Patents, Royalties, Other Intellectual Property - Stem CentRx
Travel, Accommodations, Expenses - Stem CentRx